Traduction de «million also continued » (Néerlandais → Français) :

The diabetes therapy Galvus (USD 50 million) also continued its dynamic performance in Europe, Latin America and Asia.
Galvus (USD 50 millions), traitement contre le diabète, a poursuivi sa performance dynamique en Europe, Amérique latine et Asie.

Zortress/Certican (USD 35 million, +19% cc), a transplantation medicine to prevent organ rejection in adult kidney and heart transplantation, continues to grow based on its availability in more than 80 countries and its US launch for adult kidney transplantation in April, 2010, under the brand name Zortress and is currently in two Phase III studies with global participation in heart transplantation, and also a worldwide study for liver transplantation.
Certican/Zortress (USD 35 millions, +19% tcc) est un médicament destiné à prévenir le rejet des organes dans les transplantations du rein et du cœur chez l’adulte.

Exjade (USD 179 million, +39% cc) has continued to expand on increased average dosing and improved adherence to therapy in the US, while also expanding in the Middle East.
Exjade (USD 179 millions, +39% tcc) a poursuivi son expansion suite à une augmentation du dosage moyen et à une meilleure observation du traitement aux Etats-Unis, tout en progressant également au Moyen-Orient.

The ophthalmics medicine Lucentis (USD 374 million, +44% lc) also continued to show strong gains.
Lucentis (USD 374 millions, +44% en m. l.), médicament ophtalmique, a poursuivi son ascension.

Gains were also seen in the US (USD 2.5 billion, +12% lc), while Japan (USD 889 million, +9% lc) continued to benefit from new launches in 2009.
Les Etats-Unis (USD 2,5 milliards, +12% en m. l) ont également progressé alors que le Japon (USD 889 millions, +9% en m. l) a continué de tirer profit des lancements effectués en 2009.